Cholesterol-lowering statin medications have been at the forefront of managing cardiovascular disease for several decades now. Why? Its because a large body of research supports their benefits in reducing the risk of heart attack and stroke.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
The drugs have become so universally used that if you havent been prescribed a statin already, chances are you will at some point.
Preventive cardiologist Luke Laffin, MD, says statins lower your LDL ( or bad) cholesterol, which is associated with a reduced risk of atherosclerotic cardiovascular disease. (Thats the buildup of cholesterol, fatty cells and inflammatory depositson the inner walls of your arteries aka hardening or clogging of the arteries).
Additionally, statins lower inflammation, which we know is a factor that causes atherosclerosis and cardiovascular disease, Dr. Laffin says.
Yet, despite their many benefits, statins (like all medications) have some important side effects you need to know about. So, review the risks and benefits of these important medications with your physician, and discuss your need for statin therapy.
Statins inhibit the action of an enzyme thats responsible for cholesterol production in your liver. In the process, they significantly reduce LDL and total cholesterol, while also having beneficial effects on HDL (good) cholesterol, triglycerides and inflammation. Some evidence suggests that high-intensity statin therapy may help to slow, and potentially reverse, the growth of artery-clogging atherosclerotic plaques. They may also make them less prone to rupture and cause heart attacks and strokes.
There are good data to suggest that the more LDL lowering we can achieve, the lower the risk of adverse cardiac events such as strokes and heart attacks, Dr. Laffin explains.
Although statins all belong to the same drug class, they differ in how potent they are and how much they can lower LDL cholesterol.
Your doctor will use a tool like the American College of Cardiology/American Heart Association risk calculator and other factors to gauge your long-term risk of atherosclerotic cardiovascular disease, determine if you need statin therapy, and if so, which one.
The statins are generally taken once daily and are available in generic forms. Its important to note that atorvastatin and rosuvastatin really are the workhorses of cardiology and statins at this point, Dr. Laffin adds. A lot of pharmacies typically will have one of the high-intensity statins. Theyre inexpensive and easy to obtain. In my experience, 99% of insurance companies cover at least one of them, and more than 75% cover both of them.
Guidelines from the American College of Cardiology and American Heart Association recommend statin therapy for:
* These factors include a family history of ASCVD, LDL levels persistently 160 mg/dL, triglyceride levels persistently 175 mg/dL, chronic kidney disease, ethnicity, inflammatory diseases, metabolic syndrome, and (in certain people, if measured) results of high-sensitivity C-reactive protein, lipoprotein(a), and apolipoprotein B. Note: The guidelines recommend considering coronary artery calcium scoring for people at intermediate risk in whom a decision about starting statin treatment remains uncertain.
Elevated liver enzymes. In addition to more common side effects such as headache and nausea, statins occasionally may cause increases in liver enzymes, suggesting liver inflammation. However, the latest ACC/AHA guidelines recommend liver-enzyme testing only for statin users who are at higher risk or have symptoms that may suggest liver toxicity. Furthermore, statins may cause small elevations in blood sugar, enough to push some people into the range of type 2 diabetes. But, we know that the benefits of statins outweigh that small increase in blood glucose across multiple populations, Dr. Laffin notes.
Mental fogginess. While some studies have identified positive effects of statins on cognitive function, some users have reported problems like mental fogginess and forgetfulness, which go away after stopping the drug. Overall, though, large-scale clinical trials dont suggest an increase in cognitive problems associated with statin use, Dr. Laffin says.
Muscle pain. One of the most noteworthy side effects associated with statin therapy is muscle aching and stiffness, which can be more severe as the statin dose and potency increase and may make some people intolerant to the drugs. Certain statins in particular, atorvastatin and simvastatin are more likely to cause these side effects, while others, like rosuvastatin and pravastatin, have less of an effect.
Some treatable conditions (like thyroid dysfunction and severe vitamin D deficiency) may contribute to statin intolerance. So may consuming large quantities of grapefruit (or juice) and taking certain medications. Addressing these factors may ease or prevent statin-related muscle effects. Also, some people have found that taking coenzyme Q10 supplements may help, although the ACC/AHA guidelines dont recommend their use.
Its important not to stop taking your statin and to report any muscle side effects to your physician. Your doctor may switch you to a less-potent statin, change the dose, or explore alternative dosing strategies. This may include taking the drugs every other day or less frequently. With some perseverance, you and your physician can develop a statin regimen that works for you.
Usually, you can find at least some dose of statin that people can tolerate, even if it is just a couple times a week, Dr. Laffin says. If you absolutely cannot tolerate a statin at any dose, then we have other medications we can use, such as ezetimibe (Zetia) or newer drugs known as PCSK9 inhibitors: alirocumab (Praluent) and evolocumab (Repatha).
Age is the most significant risk factor for atherosclerotic cardiovascular disease. However, the risks and benefits of statins must be carefully considered in older populations, especially those with health problems.
Older adults, as a whole, may be more likely than their younger counterparts to experience serious side effects from statins. Many seniors take multiple medications, making them more likely to experience adverse medication interactions with a statin. Importantly, seniors with other medical conditions that shorten their life expectancy may not reap the benefits of statin therapy.
So, if youre over age 75 and especially if you have other health problems discuss the pros and cons of statin therapy with your physician, Dr. Laffin advises.
The effects of statins are usually over the long termwere talking five to 10 years in terms of cardiovascular risk reduction, he explains. So, you have to balance the risk of taking another medicine versus whether you are going to die from something else in those five to 10 years. I think its very reasonable for someone who has other competing comorbidities to talk about deprescribing statins.
This article first appeared in Cleveland Clinic Mens Health Advisor.
Here is the original post:
What You Should Expect From Statin Therapy - Health Essentials from Cleveland Clinic
- Best 30 Cardiology in Secaucus, NJ with Reviews - YP.com [Last Updated On: April 12th, 2018] [Originally Added On: April 12th, 2018]
- Cardiology | Weill Cornell Medicine [Last Updated On: April 14th, 2018] [Originally Added On: April 14th, 2018]
- Cardiology Conferences 2018 | Cardiology Meetings 2018 ... [Last Updated On: April 26th, 2018] [Originally Added On: April 26th, 2018]
- Dr. Anil Goel, MD - Birmingham, MI - Cardiology & Clinical ... [Last Updated On: April 26th, 2018] [Originally Added On: April 26th, 2018]
- Clinical Physiology (Cardiology) MSc/PGDip | Middlesex ... [Last Updated On: May 15th, 2018] [Originally Added On: May 15th, 2018]
- Cardiology Conferences 2018 | Upcoming Cardiology ... [Last Updated On: May 16th, 2018] [Originally Added On: May 16th, 2018]
- Clinical Cardiology Section | Cleveland Clinic [Last Updated On: May 27th, 2018] [Originally Added On: May 27th, 2018]
- Journal of Clinical and Experimental Cardiology - Open ... [Last Updated On: June 6th, 2018] [Originally Added On: June 6th, 2018]
- Cardiology Summit 2018 | Cardiology Conferences | Heart ... [Last Updated On: June 23rd, 2018] [Originally Added On: June 23rd, 2018]
- Cardiology Clinical and Research Faculty Members ... [Last Updated On: June 26th, 2018] [Originally Added On: June 26th, 2018]
- Cardiology Conferences 2018 | Cardiology Congress 2018 ... [Last Updated On: June 26th, 2018] [Originally Added On: June 26th, 2018]
- About Us - New Jersey Cardiology Associates [Last Updated On: July 8th, 2018] [Originally Added On: July 8th, 2018]
- About Us - Ventura Clinical Trials [Last Updated On: August 16th, 2018] [Originally Added On: August 16th, 2018]
- Clinical Cardiology Made Ridiculously Simple: Michael A ... [Last Updated On: August 22nd, 2018] [Originally Added On: August 22nd, 2018]
- Clinical Cardiology - American Society of Preventive Cardiology [Last Updated On: October 2nd, 2018] [Originally Added On: October 2nd, 2018]
- Heart Surgery Hospital in india | Cardiology Treatment ... [Last Updated On: October 7th, 2018] [Originally Added On: October 7th, 2018]
- Clinical Cardiology - American Society of Preventive ... [Last Updated On: December 3rd, 2018] [Originally Added On: December 3rd, 2018]
- Guideline Clinical App - American College of Cardiology [Last Updated On: December 7th, 2018] [Originally Added On: December 7th, 2018]
- Journal of Clinical and Experimental Cardiology- Open ... [Last Updated On: December 12th, 2018] [Originally Added On: December 12th, 2018]
- Clinical Cardiology - Baptist Health [Last Updated On: December 30th, 2018] [Originally Added On: December 30th, 2018]
- Cardiology at Cancun: Topics in Clinical Cardiology [Last Updated On: February 5th, 2019] [Originally Added On: February 5th, 2019]
- Department of Cardiovascular Medicine, KU School of Medicine [Last Updated On: March 10th, 2019] [Originally Added On: March 10th, 2019]
- Towards Health Equality: Improving the Management of Cardiovascular Diseases in Women - International Atomic Energy Agency [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Lifetime Risk of PAD Varies by Race, but All Are Vulnerable to Traditional Risk Factors - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Combining Nature and Technology, Luye Medical and Cleveland Clinic Join to Build a Future Hospital in Shanghai - Yahoo Finance [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Will Renal Denervation for Hypertension Rise Again? - Medscape [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Obstructive Sleep Apnea, Sleep Symptoms, and their Association with Cardiovascular Disease - DocWire News [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- CNE expands pulmonary, sleep services with Brigham & Women's physicians - Warwick Beacon [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- What I Am Most Looking Forward to at TCT 2019 - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Serelaxin Not Linked to CV Mortality Reduction in Patients Hospitalized for Acute HF - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Sacubitril-Valsartan Not Linked to Lower Hospitalization Risk, CV Death in HFpEF - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- FDA clears multiuse angiography systems from Siemens Healthineers - DOTmed HealthCare Business News [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Balloon Pulmonary Angioplasty Effective for Chronic Thromboembolic PH - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- RWJBarnabas Health, St. Luke's University Health launch clinical affiliation - FierceHealthcare [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Bilirubin: A Novel Indicator of Infective Endocarditis Adverse Outcomes - The Cardiology Advisor [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Major Bleeding Mostly Early, Not Severe With Rivaroxaban Plus Aspirin in COMPASS - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Community-based Care Model Reduces CVD Risk - Managed Healthcare Executive [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- American College of Cardiology Steps Up: Equal Pay, Opportunities for All - TCTMD [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- FDA Approves Novo Nordisk's Oral Semaglutide, First GLP-1 in Pill Form - AJMC.com Managed Markets Network [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- A New Drug for HF? DEFINE-HF Bolsters Dapagliflozin Cardio Cred - Medscape [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- Seeking Synergy: Bringing Cardiology into Your Enterprise Imaging Strategy - Health Imaging [Last Updated On: September 21st, 2019] [Originally Added On: September 21st, 2019]
- TCT 2019 Day Two: Transcatheter Valves, New and Old - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Bypass Surgery and Coronary Stenting Yield Comparable 10-Year Survival - Diagnostic and Interventional Cardiology [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Eidos Therapeutics to Present Interim Analysis of the Ongoing Phase 2 Open-Label Extension Study of AG10 in Patients with TTR Amyloid Cardiomyopathy... [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Off Script: The New Gatekeepers of Procedural Education - TCTMD [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Study Shows Safety and Efficacy of Near Infrared Spectroscopy (NIRS) Imaging to Identify Patients and Plaques at an Increased Risk for MACE - BioSpace [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- The Heart of the Matter: Cardiovascular Fitness in Horses - United States Eventing Association [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Google parent Alphabet hires former FDA head Robert Califf to lead health strategy and policy - FierceHealthcare [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Inclisiran Benefits Patients With Familial Hypercholesterolemia and ASCVD - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- AUGUSTUS: Best Benefit With Apixaban, P2Y12 Inhibitor Dual Therapy - Medscape [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- New TAVR System Safe and Effective for High-Risk Surgical Patients with Severe Aortic Stenosis - Newswise [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Dapagliflozin Improves Heart Failure-Related Health Status in HFrEF - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Remote Ischemic Conditioning Did Not Improve 12 Month Clinical Outcomes After STEMI - The Cardiology Advisor [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Insights from the European Society of Cardiology congress | Speaking of Medicine - PLoS Blogs [Last Updated On: September 30th, 2019] [Originally Added On: September 30th, 2019]
- Smokers Have More Pulmonary Emboli, Leading to Higher Hospital Readmission Rates | - Diagnostic and Interventional Cardiology [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- AZ's Farxiga gets heart failure prevention okay from FDA - PMLiVE [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Bayer Announces Recipients of the Pulmonary Hypertension Accelerated Bayer (PHAB) Awards at CHEST Annual Meeting 2019 - BioSpace [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- The Epidemic Of The Metabolic Syndrome Among The Palestinians In The G | DMSO - Dove Medical Press [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Optina Diagnostics and the Montreal Heart Institute Partner to Develop a New Biomarker for Atherosclerosis - PRNewswire [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Even With Same Diagnosis, Women Get Half the Heart Attack Treatments as Men - AJMC.com Managed Markets Network [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Eva Dickerman, Andrew Weil - The New York Times [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- EHR vendor Veradigm and partners creating new shared data tools for researchers - Healthcare IT News [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Evolocumab Well-tolerated as Add-on for Hypercholesterolemia Therapy - DocWire News [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Deborah Heart and Lung Center announces affiliation with Cleveland Clinic Heart & Vascular Institute - Health Essentials from Cleveland Clinic [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- New Registry to Provide Insight into STEMI Occurrence, Treatment in North India | - Diagnostic and Interventional Cardiology [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Finding Your Best Fit in Cardiology - TCTMD [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Cardiology team expands to meet community need - The Union of Grass Valley [Last Updated On: October 22nd, 2019] [Originally Added On: October 22nd, 2019]
- Deaths After Ablation of Atrial Fibrillation 'Concerning' in Real-World Analysis - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cutler Family gifts $15 million to University Hospitals to transform mens health care - Newswise [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Troponin Increases After Elective PCI Tied to Complexity, Extent of CAD - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Caregiving and the Soul of Medicine - Medscape [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- STEMI Mortality Unaffected by Weekend, Weeknight, or Holiday Admission in France - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cardiva Medical publishes positive results from the AMBULATE pivotal study Cardiology2.0 - Cardiology2.0 [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Gaps in Access to TAVR and SAVR: 'Something Needs to Be Done' - TCTMD [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Cardiva Medical Announces Publication of Data From the AMBULATE Pivotal Study in the Journal of the American College of Cardiology: Clinical... [Last Updated On: November 1st, 2019] [Originally Added On: November 1st, 2019]
- Raymond James 4 Analyst Favorite Health Care Picks With Huge Upside Potential - 24/7 Wall St. [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]
- Global Computed Tomography (CT) Scanners Devices and Equipment Market Report 2020: Major Players are GE Healthcare, Koninklijke Philips, Hitachi,... [Last Updated On: November 7th, 2019] [Originally Added On: November 7th, 2019]